We have collected information about Intravail Drug Delivery Technology for you. Follow the links to find out details on Intravail Drug Delivery Technology.
https://www.neurelis.com/our-technologies
Intravail® The science of Intravail ® enables the non-invasive delivery of a broad range of protein, peptide, and non-peptide drugs, including small molecules. Intravail ® can be utilized via the oral, buccal, dermal, and intranasal routes of administration, providing several advantages:. Increased bioavailability. Addressing sub-optimal drug absorption ...
https://www.neurelis.com/neurelis-news/neurelis-acquires-aegis-therapeutics-press-release
Dec 03, 2018 · Intravail ® drug delivery technology enables the non-invasive, enhanced delivery of a broad range of protein, peptide and non-peptide drugs (up to 30,000 daltons in size) that can currently only be administered by injection. Intravail can be utilized via the oral, buccal, dermal, and intranasal administration routes of drug administration.
https://drug-dev.com/neurelis-announces-acquisition-of-leading-drug-delivery-technology-company/
Intravail drug delivery technology enables the non-invasive, enhanced delivery of a broad range of protein, peptide and non-peptide drugs (up to 30,000 Daltons in size) that can currently only be administered by injection. Intravail can be utilized via the oral, buccal, dermal, and intranasal administration routes of drug administration.
https://www.researchgate.net/publication/6963259_Intravail_Highly_effective_intranasal_delivery_of_peptide_and_protein_drugs
Intravail™: Highly effective intranasal delivery of peptide and protein drugs Article (PDF Available) in Expert Opinion on Drug Delivery 3(4):529-39 · August 2006 with 2,684 Reads
https://www.prnewswire.com/news-releases/neurelis-announces-acquisition-of-aegis-therapeutics-a-leading-drug-delivery-technology-company-300758542.html
Intravail ® drug delivery technology enables the non-invasive, enhanced delivery of a broad range of protein, peptide and non-peptide drugs (up to 30,000 daltons in size) that can currently only ...
https://www.oindpnews.com/2017/06/opiant-licenses-intravail-technology-from-aegis-therapeutics/
Jun 28, 2017 · Opiant licenses Intravail technology from Aegis Therapeutics. ... Opiant CEO Roger Crystal commented, “We are fortunate to be able to access Aegis’ proprietary Intravail drug delivery technologies for applications that may benefit patients with addictions and eating disorders. Aegis’ Intravail can improve the absorption of drugs delivered ...
https://www.in-pharmatechnologist.com/Article/2005/08/04/Aegis-Therapeutics-licenses-drug-delivery-technology
Mar 19, 2014 · Aegis' Intravail technology allows intranasal delivery of peptide and protein therapeutics that are otherwise deliverable only by injection and speeds the onset of action of small molecule drugs as well. Financial terms of the agreement were not disclosed.
https://www.pharmaceuticalonline.com/doc/aegis-therapeutics-intravail-drug-delivery-te-0001
San Dego, CA - Aegis Therapeutics recently announced that it has entered into a licensing agreement for its patented Intravail™ drug delivery technology for application to several undisclosed pediatric therapeutics being developed by an unnamed partner.
https://www.genengnews.com/topics/drug-discovery/dr-reddys-to-apply-aegis-intravail-delivery-technology-to-marketed-therapeutics/
Jan 25, 2010 · Dr. Reddy’s Laboratories negotiated access to Aegis Therapeutics’ Intravail® drug-delivery technology for use with specific marketed therapeutics that currently represent annual worldwide ...
https://www.globenewswire.com/news-release/2018/08/02/1546057/0/en/Aegis-Expands-its-International-and-US-Intravail-Patent-Portfolio-on-Multiple-Fronts.html
Aug 02, 2018 · Our Intravail® drug delivery technology enables the non-invasive delivery of a broad range of protein, peptide and non-peptide drugs that can …Author: Aegis Therapeutics LLC
Searching for Intravail Drug Delivery Technology?
You can just click the links above. The data is collected for you.
